Hansson, Oskar

Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease

Blennow, K., Stomrud, E., Zetterberg, H., Borlinghaus, N., Corradini, V., Manuilova, E., Müller-Hübner, L., Quevenco, F.-C., Rutz, S., & Hansson, O. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM)

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 30

Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease

Ahmadi, K., Pereira, J. B., Westen, D. V., Pasternak, O., Zhang, F., Nilsson, M., Stomrud, E., Spotorno, N., & Hansson, O. (2024) · The Journal of Neuroscience

Advanced Neuroimaging Techniques and ApplicationsDementia and Cognitive Impairment Research

Cited by 25

Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and diseases

Macdonald-Dunlop, E., Klarić, L., Folkersen, L., Timmers, P. R. H. J., Gustafsson, S., Zhao, J. H., Eriksson, N., Richmond, A., Enroth, S., Mattsson-Carlgren, N., et al. (2021) · medRxiv

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 9

1978 Donanemab in early symptomatic Alzheimer’s Disease: Efficacy and safety in TRAILBLAZER-ALZ 2, Phase 3 Randomized Clinical Trial

Mintun, M., Ritchie, C., Solomon, P., Sims, J. R., Salloway, S., Hansson, O., Apostolova, L. G., Zimmer, J. A., Evans, C. D., Lu, M., et al. (2024) · Age and Ageing

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 8